Noticias de NTLA_US

Noticias del mercado

Últimas noticias sobre NTLA_US — 284 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: NTLA_US ✕ 284 resultados
20/04/2026 NTLA_US — MSN ES ← EN
Las acciones de NTLA suben un 20% en 3 meses: esto es lo que debe saber

NTLA stock rises 20% in 3 months: Here's what you should know

20/04/2026 NTLA_US — The National Law Review
Shareholders that lost money on Intellia Therapeutics, Inc.(NTLA)
18/04/2026 NTLA_US — MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $19.71 Million Holdings in Intellia Therapeutics, Inc. $NTLA
18/04/2026 NTLA_US — Sahm ES ← EN
Una mirada a la valoración de Intellia Therapeutics (NTLA) después de la reciente volatilidad del precio de las acciones
16/04/2026 NTLA_US — Yahoo Finance ES ← EN
Las acciones de NTLA aumentan un 20% en 3 meses: esto es lo que debe saber
16/04/2026 NTLA_US — TradingView
NTLA Stock Rises 20% in 3 Months: Here's What You Should Know
10/04/2026 NTLA_US — Stock Titan
Intellia (NASDAQ: NTLA) revises bylaws on shareholder notices and federal forums
10/04/2026 NTLA_US — TipRanks
Intellia Therapeutics Adopts Fourth Amended and Restated Bylaws
09/04/2026 NTLA_US — Sahm
Assessing Intellia Therapeutics (NTLA) Valuation After FDA Clears MAGNITUDE Trials And Analyst Upgrade
08/04/2026 NTLA_US — Sahm
Why Intellia Therapeutics (NTLA) Is Up 14.2% After FDA Lifts MAGNITUDE Trial Holds and Upgrade
03/04/2026 NTLA_US — Intellia Therapeutics
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026 NTLA_US — Yahoo Finance
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026 NTLA_US — GlobeNewswire
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026 NTLA_US — GlobeNewswire
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/04/2026 NTLA_US — Stock Titan
13 new Intellia employees get 67,150 stock units over 3 years
03/04/2026 NTLA_US — The Norfolk Daily News
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/03/2026 NTLA_US — GuruFocus
Lawsuit for Investors in shares of Intellia Therapeutics, Inc. (
31/03/2026 NTLA_US — MarketBeat
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives Consensus Rating of "Hold" from Brokerages
27/03/2026 NTLA_US — Stock Titan
Intellia Therapeutics (NTLA) — Vanguard disaggregates holdings, parent reports 0 shares
20/03/2026 NTLA_US — Stock Traders Daily
How Intellia Therapeutics Inc. (NTLA) Affects Rotational Strategy Timing

Página 12 de 15

keyboard_arrow_up